Interference with PPARγ Function in Smooth Muscle Causes Vascular Dysfunction and Hypertension
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Cell Metabolism
- Vol. 7 (3), 215-226
- https://doi.org/10.1016/j.cmet.2007.12.008
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL38901, HL48058, HL55006, HL61446, HL62984, NS24621, T32 GM008629)
- American Heart Association (0415460Z, RR017369)
This publication has 52 references indexed in Scilit:
- Isolated Systolic Hypertension Is Characterized by Increased Aortic Stiffness and Endothelial DysfunctionHypertension, 2007
- Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistanceCell Metabolism, 2006
- Evidence Supporting a Functional Role for Intracellular Renin in the BrainHypertension, 2006
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- PPARγ Agonist Rosiglitazone Improves Vascular Function and Lowers Blood Pressure in Hypertensive Transgenic MiceHypertension, 2004
- Serotonin-Induced Contraction in Mesenteric Resistance ArteriesHypertension, 2002
- PPARγ Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 CellsCirculation Research, 2002
- Expression of Peroxisome Proliferator-Activated Receptor α (PPARα) in Primary Cultures of Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Endothelin-1 Regulates Tone of Isolated Small Arteries in the RatHypertension, 1998